Oscar Health Inc (OSCR)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $9.65B
Last updated: Nov 17, 2026 at 11:06 AM ET
Oscar Health Inc (OSCR) Financials: Revenue, Profit and Cash Flow
Oscar Health reported revenue of $11.70B for the fiscal year ended Dec 31, 2025, up 27.5% from the year before. That year, net income was -$442.90M with a net margin of -3.8%, operating cash flow was $1.09B and free cash flow was $1.06B. The quarter ended Sep 30, 2026 had revenue of $5.14B and net income of $167.30M.
Revenue and Margins
The operating margin was -3.4% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $488.19M, a compound annual rate of 69.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $11.70B | +27.5% | 100.0% | -3.4% | -3.8% |
| Dec 2024 | $9.18B | +56.5% | 100.0% | 0.6% | 0.3% |
| Dec 2023 | $5.86B | +47.9% | 100.0% | -4.0% | -4.6% |
| Dec 2022 | $3.96B | +115.6% | 17.2% | -14.9% | -15.4% |
| Dec 2021 | $1.84B | +297.3% | 11.7% | -29.6% | -31.1% |
| Dec 2020 | $462.80M | -5.2% | 33.2% | -86.9% | -87.9% |
| Dec 2019 | $488.19M | N/A | 16.4% | -53.1% | -53.5% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $462.80M | $488.19M |
| Cost of revenue | $0 | $0 | $0 | $3.28B | $1.62B | $309.35M | $408.26M |
| Gross profit | $11.70B | $9.18B | $5.86B | $682.84M | $214.72M | $153.45M | $79.93M |
| Operating income | -$396.36M | $57.27M | -$235.62M | -$589.87M | -$544.48M | -$402.27M | -$259.39M |
| Net income | -$442.90M | $26.12M | -$270.59M | -$609.55M | -$571.43M | -$406.82M | -$261.18M |
| EBITDA | N/A | $63.21M | N/A | -$568.98M | -$522.72M | -$388.07M | -$259.14M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B |
| Gross profit | $906.45M | $1.09B | $1.42B | $10.20B | $399.65M | $310.97M | $786.61M | $5.66B | $2.42B | $510.62M | $587.53M | $3.78B |
| Operating income | $178.02M | $388.63M | $704.09M | -$333.75M | -$129.25M | -$230.48M | $297.12M | -$147.73M | -$48.37M | $67.81M | $185.56M | -$145.48M |
| Net income | $167.30M | $361.83M | $679.02M | -$352.43M | -$137.48M | -$228.49M | $275.51M | -$153.28M | -$54.39M | $56.31M | $177.48M | -$149.84M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded long-term debt of $430.10M by $2.34B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | $1.35B |
| Current assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | $725.59M |
| Cash and equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826.33M | $336.64M |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | $494.24M |
| Long-term debt | $430.10M | $299.56M | $298.78M | $298.00M | $0 | $142.49M | N/A |
| Shareholder equity | $977.65M | $1.01B | $803.97M | $890.38M | $1.39B | -$1.30B | $852.68M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.01B | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | $3.60B |
| Total liabilities | $7.78B | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | $2.80B |
| Cash and equivalents | $4.47B | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B |
| Shareholder equity | $2.22B | $2.05B | $1.66B | $977.65M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | $803.97M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 97.2% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $978.19M | -$272.16M | $380.35M | -$181.75M | $222.73M | -$165.37M |
| Capital expenditures | $36.37M | $27.90M | $25.58M | $29.01M | $25.89M | $14.02M | $26.00M |
| Free cash flow | $1.06B | $950.30M | -$297.74M | $351.34M | -$207.63M | $208.71M | -$191.37M |
| Share repurchases | N/A | N/A | N/A | N/A | $9.45M | $0 | $2.99M |
| Investing cash flow | -$241.06M | -$1.39B | $577.19M | -$226.52M | -$774.51M | -$344.71M | $150.51M |
| Financing cash flow | $399.21M | $68.39M | $6.45M | $301.11M | $1.24B | $611.71M | -$2.12M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.20B | $2.09B | $2.62B | $671.90M | -$964.66M | $509.07M | $878.54M | $346.82M | -$500.14M | $497.15M | $634.36M | $296.87M |
| Capital expenditures | $11.31M | $11.76M | $8.79M | $9.06M | $9.01M | $9.28M | $9.03M | $6.82M | $7.57M | $7.56M | $5.95M | $6.10M |
| Free cash flow | -$1.21B | $2.08B | $2.61B | $662.84M | -$973.66M | $499.79M | $869.52M | $340.00M | -$507.71M | $489.59M | $628.41M | $290.77M |
Frequently Asked Questions About OSCR
What is Oscar Health's annual revenue?
Oscar Health reported revenue of $11.70B for the fiscal year ended Dec 31, 2025.
How fast is Oscar Health's revenue growing?
Revenue was up 27.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 43.5%.
Is Oscar Health profitable?
No. Oscar Health reported net income of -$442.90M for the fiscal year ended Dec 31, 2025, with a net margin of -3.8%.
How much free cash flow does OSCR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.09B minus capital expenditures of $36.37M produced free cash flow of $1.06B.
How much debt does Oscar Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $430.10M and cash and equivalents of $2.77B.
OSCR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors